AIR is a trial management organization bringing together physicians and pharmaceutical companies to explore the future of medicine through clinical trials.
A leader in the field of clinical trials.
Dedicated to patient care.
With a diverse population and a network of compassionate and experienced physicians, AIR helps serve the medical community in most therapeutic areas.
The American Institute of Research is profoundly dedicated to conduct clinical trials in the most ethical manner. We strive to be at the forefront of medical research and patient care to pave the way for advancements in medicine. We commit to the highest quality of care for our patients, and will always strive to be at our utmost levels of compassion and empathy.
To bring about the perfection of modern medicine for the betterment of humankind.
We are grateful to everyone who made the choice to participate in the COVID-19 Oral Treatment studies.
Thanks to your commitment, PAXLOVID™ (PF-07321332; ritonavir) has received United States Food and Drug Administration Emergency Use Authorization (EUA) for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds) with positive results of direct SARS-CoV-2 testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death.
You should feel proud of your contribution to help millions of people impacted by COVID-19.
Your participation is changing the course of this pandemic, and quite literally, the world.
On behalf of the Pfizer study team and American Institute of Research, Thank You!
Click Here for a Thank You message from Pfizer